Health Canada has approved Pfizer’s COVID-19 booster vaccine for children five to 11 years old following approval two months ago of the same shot for individuals 12 years and older.
“After a thorough and independent scientific review of the evidence, Health Canada has determined that the Pfizer-BioNTech Comirnaty Omicron BA.4/BA.5 bivalent-adapted booster vaccine for children 5 to 11 years of age is safe and effective and that its benefits outweigh any potential risks,” the department said in a news release on Dec. 9.
